
Quinazoline and Quinoline Derivatives
Quinazolines and quinolines are nitrogen-containing heterocyclic compounds with aromatic structures that play a key role in the synthesis of drugs with anticancer, antimicrobial, and anti-inflammatory activity. Their derivatives feature structural modifications that optimise bioavailability and selectivity, enabling the development of new active ingredients for various therapeutic applications. These compounds are used in the manufacture of APIs for the treatment of cancer, infections, neurodegenerative diseases, and cardiovascular conditions. Additionally, quinazoline and quinoline derivatives are essential in the research of enzyme inhibitors and the design of innovative bioactive molecules.
At CymitQuimica, we offer high-purity quinazoline and quinoline derivatives for applications in chemical synthesis, pharmaceutical development, and biotechnology.
Found 65576 products of "Quinazoline and Quinoline Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
1-(3-Amino-2-methyl-benzyl)-4-(2-thiophen-2-yl-ethoxy)-2-pyridone
CAS:Purity:97.0%Color and Shape:SolidMolecular weight:340.44000244140625Ethyl 5-amino-1-(1,3-benzothiazol-2-yl)-1H-pyrazole-4-carboxylate
CAS:Purity:95.0%Molecular weight:288.3299865722656(2-Amino-benzothiazol-6-yl)-morpholin-4-yl-methanone
CAS:Purity:95+%Color and Shape:SolidMolecular weight:263.320007324218756-Bromo-2-p-tolylquinoline-4-carboxylic acid
CAS:Color and Shape:SolidMolecular weight:342.19198608398446-Bromo-3-methyl-2-p-tolylquinoline-4-carboxylic acid
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:356.218994140625Sibutramine Hydrochloride Monohydrate 1.0 mg/ml in Methanol (as anhydrous free base)
CAS:Color and Shape:Single Solution1,3-Bis(4-bromophenyl)-1H-pyrazol-5-ylamine
CAS:Purity:99.0%Color and Shape:Solid, Off-white flakes powderMolecular weight:393.08200073242197-Thiophen-2-yl-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid
CAS:Color and Shape:SolidMolecular weight:245.259994506835941-(4-Fluoro-phenyl)-3-phenyl-1H-pyrazole-5-carboxylic acid
CAS:Purity:98.0%Color and Shape:SolidMolecular weight:282.273986816406252-(1H-Pyrazol-4-yl)quinoline
CAS:Purity:99.0%Color and Shape:SolidMolecular weight:195.225006103515622-Pyridin-3-yl-1 H -benzoimidazol-5-ylamine
CAS:Purity:98+%Color and Shape:SolidMolecular weight:210.24000549316406Vortioxetine-D8.HBr, 0.1mg/ml in Methanol (as free base)
Formula:C18D8H14N2S·BrHColor and Shape:Single SolutionAripiprazole metabolite-D6 (OPC-3373-D6), 0.1mg/ml in Ethanol
Formula:C13D6H9NO4Color and Shape:Single Solution4-Cyclopropyl-5-[2-(3,5-dimethyl-pyrazol-1-yl)-ethyl]-4H-[1,2,4]triazole-3-thiol
CAS:Purity:97%Color and Shape:SolidMolecular weight:263.1204665442-(3-Chloro-phenyl)-3-methylquinoline-4-carboxylic acid
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:297.7399902343756-Bromo-2-(2,5-dimethyl-thiophen-3-yl)-quinoline-4-carboxylic acid
CAS:Color and Shape:SolidMolecular weight:362.2399902343754-(3-Pyridin-2-yl-1H-pyrazol-4-yl)quinoline
CAS:Purity:97.0%Color and Shape:Solid, Crystalline PowderMolecular weight:272.3110046386719(4-Oxo-3-phenyl-3,4-dihydro-quinazolin-2-ylsulfanyl)-acetic acid
CAS:Color and Shape:SolidMolecular weight:312.33999633789062-Amino-4-biphenyl-4-yl-thiophene-3-carboxylic acid methyl ester
CAS:Purity:97%Color and Shape:SolidMolecular weight:309.3800048828125PK-11195
CAS:<p>M02235 - PK-11195</p>Formula:C21H21ClN2OPurity:>98%Color and Shape:SolidMolecular weight:352.86(2E)-3-[3-(3-bromophenyl)-1-phenyl-1H-pyrazol-4-yl]acrylic acid
CAS:Purity:95.0%Molecular weight:369.21798706054692-Benzyl-2-dimethylamino-1-(4-morpholinophenyl)-1-butanone
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:366.50500488281252-(1H-Pyrazol-4-yl)quinoxaline
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:196.21299743652344d,l-Methcathinone.HCl, 1mg/ml in Acetonitrile (as free base)
CAS:Controlled ProductColor and Shape:Single SolutionDiphthalimido Morpholinone Analog (2,2'-((2R,2'R)-((4-(3-oxomorpholino)phenyl)azanediyl)bis(2-hydroxypropane-3,1-diyl))bis(isoindoline-1,3-dione))
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C32H30N4O8Color and Shape:Pale Yellow SolidMolecular weight:598.20636Teriflunomide Related Compound B (2-Cyano-N-(4-(trifluoromethyl)phenyl)acetamide)
CAS:Nitrile function compounds, nesoiFormula:C10H7F3N2OColor and Shape:White Yellow Crystalline PowderMolecular weight:228.05105Regorafenib
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C21H15ClF4N4O3·H2OColor and Shape:White Brown PowderMolecular weight:500.08745Oxcarbazepine Related Compound E (10(11H)-Oxo-5H-dibenz[b,f]azepine)
CAS:<p>Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoi</p>Formula:C14H11NOColor and Shape:PowderMolecular weight:209.08406Metoprolol Fumarate
CAS:Aromatic drugs of amino-alcohols, other than those contFormula:C34H54N2O10Color and Shape:White Off-White Crystalline PowderMolecular weight:650.8N-Isopropyl Carvedilol (1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl](1-methylethyl)amino]-2-propanol)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C27H32N2O4Color and Shape:Off-White SolidMolecular weight:448.23621Atazanavir amine analog methyl ((S)-1-(((2S,3S)-4-(2-((S)-2-amino-3,3-dimethylbutanoyl)-1-(4-(pyridin-2-yl)benzyl)hydrazinyl)-3-hydroxy-1-phenylbutan-2-yl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C36H50N6O5Color and Shape:Off-White SolidMolecular weight:646.38427Clioquinol Related Compound A (5-Chloroquinolin-8-ol)
CAS:Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFormula:C9H6ClNOColor and Shape:Off-White PowderMolecular weight:179.01379Rivaroxaban phthalimido ethyl ester analog ((S)-1-(1,3-dioxoisoindolin-2-yl)-3-((ethoxycarbonyl)(4-(3-oxomorpholino)phenyl)amino)propan-2-yl 5-chlorothiophene-2-carboxylate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C29H26ClN3O8SColor and Shape:White Off-White SolidMolecular weight:611.11291Levetiracetam Crotonamide ((Z)-2-(2-oxopyrrolidin-1-yl)but-2-enamide)
CAS:Lactams, nesoiFormula:C8H12N2O2Color and Shape:White Off-White SolidMolecular weight:168.08988Leflunomide Related Compound A (4-(trifluoromethyl)aniline)
CAS:Toluidines (aminotoluenes) and their derivatives, salts thereofFormula:C7H6F3NColor and Shape:White Light Yellow LiquidMolecular weight:161.04523Brivaracetam Related Compound D ((S)-2-[(R)-2-Oxo-4-propylpyrrolidin-1-yl]butanoic acid)
CAS:Lactams, nesoiFormula:C11H19NO3Color and Shape:White Off-White Fine PowderMolecular weight:213.13649Desethylamiodarone (2-Butyl-3-benzofuranyl-4-[2-(ethylamino)ethoxy]-3,5-diiodophenyl Ketone Hydrochloride)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C23H25I2NO3·HClColor and Shape:White Off-White SolidMolecular weight:652.96907Nadolol Related Compound F (1-(tert-Butylamino)-3-(naphthalen-1-yloxy)propan-2-ol)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormula:C17H23NO2Color and Shape:Off-White SolidMolecular weight:273.17288Erlotinib Hydrochloride
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormula:C22H23N3O4·HClColor and Shape:Pale Yellow PowderMolecular weight:429.14553Carbomer Homopolymer
CAS:Other acrylic polymers in primary forms (excluding elastomeric)Color and Shape:White Powder4-Chloro Omeprazole (2-[(RS)-[4-Chloro-3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C16H16ClN3O2SColor and Shape:Off-White SolidMolecular weight:349.065184-(Pyridin-2-yl)benzaldehyde (4-(Pyridin-2-yl)benzaldehyde)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C12H9NOColor and Shape:Pale Yellow Off-White PowderMolecular weight:183.06841Dehydroargatroban Trifluoroacetate ((2R,4R)-4-Methyl-1-{[(3-methylquinolin-8-yl)sulfonyl]-L-arginyl}piperidine-2-carboxylic acid Trifluoroacetate)
Sulfonamides, nesoiFormula:C23H32N6O5S·C2HF3O2Color and Shape:Off-White PowderMolecular weight:504.21549Rivaroxaban Related Compound B ((S)-N-({2-Oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)acetamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H19N3O5Color and Shape:White Off-White SolidMolecular weight:333.13247Polyvinyl Alcohol
CAS:Polyvinyl alcohols, whether or not containing unhydrolyzed acetate groupsFormula:H(C2H4O)m(C4H6O2)nHColor and Shape:PowderMolecular weight:46.0684Bupropion Amine Tosylate (2-Amino-1-(3-chloro-phenyl)-1-propanone 4-methylbenzenesulfonate)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormula:C16H18ClNO4SColor and Shape:White SolidMolecular weight:355.06451Paroxetine Related Compound C ((3R,4S)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride) OR ((+)-trans-Paroxetine hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H20FNO3·HClColor and Shape:White PowderMolecular weight:365.1194Omeprazole Related Compound E (4-Methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-3,5-dimethylpyridine 1-oxide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C17H19N3O4SColor and Shape:Off-White PowderMolecular weight:361.10963Clozapine Resolution Mixture
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureColor and Shape:Yellow Crystalline PowderMolecular weight:203.09061Fluvoxamine Z-isomer Maleate ((Z)-5-methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one O-(2-aminoethyl) oxime maleate)
CAS:Aromatic organic derivatives of hydrazine or of hydroxylamineFormula:C15H21F3N2O2·C4H4O4Color and Shape:White SolidMolecular weight:318.15551Methylparaben
CAS:Carboxylic acids with phenol function but without otherFormula:C8H8O3Color and Shape:White Crystalline PowderMolecular weight:152.15Argatroban Related Compound C ((2R,4R)-1-[N^8-amino- N^2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid)
Sulfonamides, excluding drugsFormula:C23H37N7O5SColor and Shape:Off-White PowderMolecular weight:523.25769Carvedilol Related Compound A (1-(4-(2-hydroxy-3-(2-(2-methoxyphenoxy)ethylamino)propoxy)-9H-carbazol-9-yl)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFormula:C36H43N3O7Color and Shape:PowderMolecular weight:629.3101Bicalutamide
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C18H14F4N2O4SColor and Shape:White Off-White PowderMolecular weight:430.06104Duloxetine Related Compound F ((S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H19NOS·HClColor and Shape:Off-White PowderMolecular weight:333.09541Omeprazole Related Compound B (5-Methoxy-1H-benzimidazol-2-thiol)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C8H8N2OSColor and Shape:White Off-White PowderMolecular weight:180.035734-Phenylbutyl(benzyl)amine hydrochloride (N-benzyl-4-phenylbutan-1-amine, hydrochloride)
CAS:Aromatic monoamines and their derivatives, salts thereof, nesoiFormula:C17H21N·HClColor and Shape:White Off-White SolidMolecular weight:239.1674Oxcarbazepine Related Compound C (Acridin-9(10H)-one)
CAS:Aromatic or modified aromatic heterocyclic compounds wiFormula:C13H9NOColor and Shape:Yellow Green SolidMolecular weight:195.06841Paroxetine Related Compound F ((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methylpiperidine)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formula:C20H22FNO3Color and Shape:Light Tan PowderMolecular weight:343.15837Bicalutamide Related Compound B ((RS)-N-(4-Cyano-3-(trifluoromethyl)phenyl)-3-(3-fluorophenylsulfonyl)-2-hydroxy-2-methylpropanamide)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C18H14F4N2O4SColor and Shape:White Pale Pink PowderMolecular weight:430.37Salmeterol Related Compound A (4-[1-Hydroxy-2-(4-phenylbutylamino)ethyl]-2-(hydroxymethyl)phenol 1-hydroxy-2-naphthoate)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C19H25NO3·C11H8O3Color and Shape:White PowderMolecular weight:315.18344Aleuritic Acid
CAS:Carboxylic acids w/ alcohol function but w/o other oxygen function and their derivatives, nesoiFormula:C16H32O5Color and Shape:PowderMolecular weight:304.22497Ondansetron Hydrochloride
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C18H19N3O·HCl·2H2OColor and Shape:White Off-White PowderMolecular weight:293.15281Apixaban
CAS:Lactams, nesoiFormula:C25H25N5O4Color and Shape:Off-White White SolidMolecular weight:459.19065Methyl Alcohol
CAS:Methanol (methyl alcohol)Formula:CH4OColor and Shape:Colorless Clear LiquidMolecular weight:32.02621Rivaroxaban Open Oxomorpholine Ring ((S)-5-chloro-N-((3-(4-(2-hydroxy-N-(2-hydroxyethyl)acetamido) phenyl)-2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H20ClN3O6SColor and Shape:White Off-White SolidMolecular weight:453.07613Bicalutamide Related Compound A (N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluoro-phenyl)sulfinyl]-2-hydroxy-2-methyl-propanamide)
Other aromatic organo-sulfur compounds (excluding pesticides)Color and Shape:PowderMolecular weight:414.38Dealkyl Atazanavir (Methyl [(5S,10S,11S,14S)-11-benzyl-5-(tert-butyl)-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C26H43N5O7Color and Shape:White PowderMolecular weight:537.31625Mirabegron
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C21H24N4O2SColor and Shape:White Off-White Brownish Yellow Crystalline PowderMolecular weight:396.162Naproxen Related Compound G ((R)-2-(6-Methoxynaphthalen-2-yl)propanoic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFormula:C14H14O3Color and Shape:PowderMolecular weight:230.09429Fluphenazine Decanoate N4-oxide
CAS:Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFormula:C32H44F3N3O3SColor and Shape:Off-White PowderMolecular weight:607.30555Sodium Starch Glycolate Type B
CAS:Dextrins, nesoiFormula:C2H4O3·xNa·xUnspecifiedColor and Shape:Off-White White PowderMolecular weight:515.6862Regorafenib Related Compound A (4-(4-Amino-3-fluorophenoxy)-N-methylpicolinamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C13H12FN3O2Color and Shape:Brown Violet PowderMolecular weight:261.09135Methoxyethyl Phenol
CAS:Ether-phenols, ether-alcohol-phenols and their halogenated, sulfonated, nitrated or nitrosated derivativesFormula:C9H12O2Color and Shape:White PowderMolecular weight:152.08373Prasugrel Related Compound D (5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H18FNO2SColor and Shape:Off-White PowderMolecular weight:331.10423Naproxen Related Compound K (1-(6-Methoxynaphthalen-2-yl)ethanol)
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives, nesoiFormula:C13H14O2Color and Shape:White Crystalline PowderMolecular weight:202.09938Hydroxybenzoyl Paliperidone (3-(2-(4-(4-fluoro-2-hydroxybenzoyl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C23H28FN3O4Color and Shape:Off-White SolidMolecular weight:429.20638Anastrozole Nitrile Acid (2-{3-[(1H-1,2,4-Triazol-1-yl)methyl]-5-(2-cyanopropan-2-yl)phenyl}-2-methylpropanoic acid)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C17H20N4O2Color and Shape:White PowderMolecular weight:312.15863Levetiracetam
CAS:Lactams, nesoiFormula:C8H14N2O2Color and Shape:White PowderMolecular weight:170.10553Oxcarbazepine Related Compound A (N-Formyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide)
Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C16H12N2O3Color and Shape:Pale Yellow PowderMolecular weight:280.08479Sorafenib Isopropyl Carbamate (Isopropyl {4-[2-(methylcarbamoyl)pyridin-4-yl]oxyphenyl}carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C17H19N3O4Color and Shape:Off-White PowderMolecular weight:329.13756Metoprolol Succinate
CAS:Aromatic drugs of amino-alcohols, other than those contg > one kind of oxygen function, their ethers and esters; salts thereof, nesoiFormula:(C15H25NO3)2·C4H6O4Color and Shape:White Off-White PowderMolecular weight:534.36689Refined Bleached Shellac
CAS:Natural gums, gum resins, resins and balsams nesoiColor and Shape:PowderParoxetine Related Compound G ((+/-)trans-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4''-fluorophenyl-4'-phenyl)piperidine hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C25H24FNO3·HClColor and Shape:White Off-White PowderMolecular weight:441.92Ranitidine Hydrochloride
CAS:Compounds containing an unfused furan ring (whether or not hydrogenated) in the structure nesoiFormula:C13H22N4O3S·HClColor and Shape:White Pale Yellow PowderMolecular weight:350.11794Omeprazole Magnesium
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C34H36MgN6O6S2Color and Shape:White Off-White PowderMolecular weight:712.19882Atazanavir Sulfate Valine Analog (methyl ((5S,10S,11S,14S)-11-benzyl-5-(tert-butyl)-10-hydroxy-15-methyl-3,6,13-trioxo-8-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,8,12-tetraazahexadecan-14-yl)carbamate sulfate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C37H50N6O7·H2SO4Color and Shape:Off-White SolidMolecular weight:690.3741Aripiprazole Related Compound G (7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}quinolin-2(1H)-one)
CAS:Lactams, nesoiFormula:C23H25Cl2N3O2Color and Shape:White Light Yellow Crystalline PowderMolecular weight:445.13238Anhydrous Lactose (A Mixture of α and β anomers)
CAS:Lactose and lactose syrup, containing by weight 99% or more lactose, expressed as anhydrous lactose, calculated on the dry matterFormula:C12H22O11Color and Shape:White Off-White PowderMolecular weight:342.11621Paliperidone
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C23H27FN4O3Color and Shape:White PowderMolecular weight:426.20672Atazanavir Formyl Analog (methyl ((S)-1-(((2S,3S)-4-(2-((S)-2-formamido-3,3-dimethylbutanoyl)-1-(4-(pyridin-2-yl)benzyl)hydrazinyl)-3-hydroxy-1-phenylbutan-2-yl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C37H50N6O6Color and Shape:Off-White SolidMolecular weight:674.37918Ofloxacin Related Compound A (9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C17H18FN3O4Color and Shape:Light Yellow PowderMolecular weight:347.12813Ezetimibe
CAS:Lactams, nesoiFormula:C24H21F2NO3Color and Shape:White PowderMolecular weight:409.14895Apixaban Related Compound E (Methyl 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS:Lactams, nesoiFormula:C26H26N4O5Color and Shape:Off-White Light Brown Cream PowderMolecular weight:474.19032Rivaroxaban N-methylphthalamido Analog ((S)-N1-methyl-N2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C23H24N4O6Color and Shape:White Off-White SolidMolecular weight:452.16958Oxcarbazepine Related Compound B (N-Acetyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C17H14N2O3Color and Shape:White Yellow PowderMolecular weight:294.10044Ondansetron Related Compound A (3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride)
CAS:Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C16H20N2O·HClColor and Shape:White SolidMolecular weight:256.15756Fluphenazine Hydrochloride
CAS:Antidepressants, tranquilizers and other pschotherapeutic agentsFormula:C22H26F3N3OS·2ClHColor and Shape:White Off-White Crystalline PowderMolecular weight:509.12822Salmeterol System Suitability (Mixture containing salmeterol xinafoate, salmeterol-N-alkyl and salmeterol related compound H)
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:White PowderCarvedilol
CAS:Cardiovascular drugs, nesoiFormula:C24H26N2O4Color and Shape:White Off-White Crystalline PowderMolecular weight:406.18926Darunavir Ethanolate
CAS:Sulfonamides used as drugsFormula:C27H37N3O7S·C2H6OColor and Shape:White Beige PowderMolecular weight:593.27709Rivaroxaban Related Compound G ((S)-2-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)isoindoline-1,3-dione)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C22H19N3O6Color and Shape:White Off-White SolidMolecular weight:421.12739Aminophenylmorpholin-2-one (4-(4-aminophenyl)morpholin-2-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C10H12N2O2Color and Shape:Pale Yellow SolidMolecular weight:192.08988Rivaroxaban R-enantiomer ((R)-5-Chloro-N-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)thiophene-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H18ClN3O5SColor and Shape:Yellow White SolidMolecular weight:435.06557Rivaroxaban Amine ((S)-4-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one, hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C14H17N3O4·HClColor and Shape:Off-White SolidMolecular weight:327.09858Rotigotine Hydrochloride Ethyl Analog ((S)-6-(ethyl(2-(thiophen-2-yl)ethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H24ClNOSColor and Shape:Beige SolidMolecular weight:337.12671Naproxen Related Compound E ((S)-Methyl 2-(6-methoxynaphthalen-2-yl)propanoate)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormula:C15H16O3Color and Shape:White Crystalline PowderMolecular weight:244.10994Rotigotine ((S)-6-{Propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H25NOSColor and Shape:White Beige PowderMolecular weight:315.16569Argatroban Related Compound B (Ethyl (4R)-1-[N^8-nitro-L-arginyl]-4-methylpiperidine-2-carboxylate dihydrochloride)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C15H28N6O5·2HClColor and Shape:Off-White PowderMolecular weight:444.16547Rotigotine Hydrochloride ((6S )-6-[Propyl(2-(2-thienyl)ethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H25NOSHClColor and Shape:White Off-White PowderMolecular weight:315.16569Desacetyl Apremilast ((S)-4-Amino-2-[1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]isoindoline-1,3-dione)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C20H22N2O6SColor and Shape:Yellow PowderMolecular weight:418.11986Plerixafor
CAS:Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C28H54N8Color and Shape:White Off-White PowderMolecular weight:502.44714Silodosin S-Enantiomer
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C25H32F3N3O4Color and Shape:White Off-White Crystalline PowderMolecular weight:495.23449Bicalutamide Sulfide (N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenylthio)-2-hydroxy-2-methylpropanamide)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C18H14F4N2O2SColor and Shape:White PowderMolecular weight:398.07121Duloxetine Related Compound A ((R)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H19NOS·HClColor and Shape:Off-White SolidMolecular weight:297.11874Fluvoxketone (5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one)
CAS:Ketones and quinones, w/not with other oxygen function,and their halogenated,sulfated,nitrated,or nitrosated derivatives, nesoiFormula:C13H15F3O2Color and Shape:White PowderMolecular weight:260.10241Methylisoindolinedione (2-methylisoindoline-1,3-dione)
CAS:Imides and their derivatives (excluding sacharin), and salts thereofFormula:C9H7NO2Color and Shape:White Off-White SolidMolecular weight:161.04768Carvedilol Related Compound B (3,3'-(2-(2-methoxyphenoxy)ethylazanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol))
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormula:C39H39N3O6Color and Shape:Off-White PowderMolecular weight:645.28389Chlorothiophene Aldehyde (5-chlorothiophene-2-carbaldehyde)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C5H3ClOSColor and Shape:Brown LiquidMolecular weight:145.95931Bupropion Hydrochloride Related Compound C (1-(3-chlorophenyl)-2-hydroxypropan-1-one)
CAS:Aromatic ketone-alcohols and ketone-aldehydes, nesoiFormula:C9H9O2ClColor and Shape:LiquidMolecular weight:184.02911Fluconazole Related Compound B (2-(4-Fluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)-propan-2-ol)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C13H13FN6OColor and Shape:White PowderMolecular weight:288.11349Leflunomide Tolyl Analog (5-Methyl-N-(4-methylphenyl)-4-isoxazolecarboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C12H12N2O2Color and Shape:White PowderMolecular weight:216.08988Apixaban Related Compound D (N-Formyl-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide)
CAS:Lactams, nesoiFormula:C26H25N5O5Color and Shape:White Off-White PowderMolecular weight:487.18557N-Nitroso Metoprolol Solution (1 mL ) (N-(2-hydroxy-3-(4-(2-methoxyethyl)phenoxy)propyl)-N-isopropylnitrous amide)
CAS:Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiFormula:C15H24N2O4Color and Shape:Colorless LiquidMolecular weight:296.17361Rivaroxaban Glycolic Acid Analog ((S)-2-(2-((4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)amino)ethoxy)acetic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H20ClN3O6SColor and Shape:Pale Yellow SolidMolecular weight:453.07613Aripiprazole Acid Analog (4-((2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy)butanoic acid)
CAS:Lactams, nesoiFormula:C13H15NO4Color and Shape:White Off-White SolidMolecular weight:249.10011Topiramate Related Compound A (2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose)
CAS:Heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C12H20O6Color and Shape:White PowderMolecular weight:260.12599Metoprolol Related Compound B ((+/-)1-Chloro-2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]-propane)
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormula:C12H17ClO3Color and Shape:Pale Yellow Clear LiquidMolecular weight:244.08662Desthiophenerivaroxaban Methylcarbamate Analog (methyl ((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)carbamate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H19N3O6Color and Shape:White Off-White SolidMolecular weight:349.12739R,R,S-Ezetimibe ((3R,4S)-1-(4-fluorophenyl)-3-((R)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one)
CAS:Lactams not elsewhere specified or includedFormula:C24H21F2NO3Color and Shape:White Off-White SolidMolecular weight:409.14895Tazarotene Related Compound B (Ethyl 6-chloronicotinate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C8H8ClNO2Color and Shape:Colorless Material Melts At 30⁰ C And Becomes Liquid However The Material Is In Solid State At Below 25⁰CMolecular weight:185.02436Carvedilol Bisalkylpyrocatechol derivative (3,3'-{2,2'-[1,2-Phenylenebis(oxy)]bis(ethane-2,1-diyl)}bis(azanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol))
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C40H42N4O6Color and Shape:Off-White Light Brown SolidMolecular weight:674.31044Nilotinib Related Compound B (Methyl 3-amino-4-methylbenzoate)
CAS:Aromatic amino-acids and their esters, other than those containing more than one kind of oxygen function, nesoiFormula:C9H11NO2Color and Shape:Off-White Light Yellow PowderMolecular weight:165.07898Deschloro Bupropion Hydrochloride (2-(tert-Butylamino)-1-phenylpropan-1-one hydrochloride)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormula:C13H19NO·HClColor and Shape:White PowderMolecular weight:241.12334Fluconazole
CAS:Anti-infective agents, nesoiFormula:C13H12F2N6OColor and Shape:White Off-White PowderMolecular weight:306.10407Paroxetine Hydrochloride
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H20FNO3·HClH2OColor and Shape:White Off-White Crystalline PowderMolecular weight:329.14272Deoxybicalutamide (N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenylsulfonyl)-2-methylpropanamide)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C18H14F4N2O3SColor and Shape:SolidMolecular weight:414.06613Metoprolol Dimer (1,3-Bis[4-(2-methoxyethyl)phenoxy]propan-2-ol)
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives, nesoiFormula:C21H28O5Color and Shape:Colorless Light Yellow LiquidMolecular weight:360.19367Apixaban Related Compound F (Ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS:Lactams, nesoiFormula:C22H20N4O6Color and Shape:Light Brown PowderMolecular weight:436.13828Naproxen Related Compound A (6-methoxy-2-naphthoic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormula:C12H10O3Color and Shape:White Off-White PowderMolecular weight:202.06299Naproxen Related Compound L (1-(6-methoxynaphthalen-2-yl)ethanone)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFormula:C13H12O2Color and Shape:White Crystalline PowderMolecular weight:200.08373



